Beijing Biostar Pharmaceuticals Co., Ltd.

This study tests a new drug called utidelone combined with standard chemotherapy for people with advanced stomach or gastroesophageal junction cancer that has not been treated before. The goal is to see if the combination helps patients live longer and controls the disease better…